AMANTA HEALTHCARE LIMITED
Price Band
₹ 120 - ₹ 126
Bid Lot
119 Shares
Price Band
₹ 120 - ₹ 126
Minimum Investment
₹ 14994.00
Bid Lot
119 Shares
Shares
10,000,000
-
Face Value - Rs. 10/- Per Share
- Lisitng at BSE, NSE
-
29,411 Application Required in Retail for 1 Time.
-
Registrar : Link Intime India Private Ltd
IPO Details
QIB
50%
(5,000,000 Shares)RS.63.00 CR
HNI 1
5%
(500,000 Shares)RS.6.30 CR @ 300 FORM 1X
HNI 2
10%
(1,000,000 Shares)RS.12.60 CR @ 600 FORM 1X
Retail
35%
(3,500,000 Shares)RS.44.10 CR @ 29412 FORM 1X
Timeline
-
01
Sep-2025
Open Date
-
03
Sep-2025
Close Date
-
04
Sep-2025
Basis of Allotment Date
-
05
Sep-2025
Initiation of Refunds
-
05
Sep-2025
Credit of Shares to Demat A/C
-
08
Sep-2025
IPO Listing Date
Subscription as on 04-Sep-2025 16:49
Category
Book Size
Subscription
QIB
28.93x
2,000,000
(₹25.20 Cr.)
57,851,136
(₹728.92 Cr.)
HNI (<10 LAKH)
113.16x
500,000
(₹6.30 Cr.)
56,580,216
(₹712.91 Cr.)
HNI2 (>10 LAKH)
158.99x
1,000,000
(₹12.60 Cr.)
158,988,879
(₹2003.26 Cr.)
RETAIL
34.86x
3,500,000
(₹44.10 Cr.)
122,010,581
(₹1537.33 Cr.)
Total
56.49x
7,000,000
395,430,812
Category
Book Size
Subscription
QIB
28.93x
2,000,000
(₹25.20 Cr.)
57,851,136
(₹728.92 Cr.)
HNI (<10 LAKH)
113.16x
500,000
(₹6.30 Cr.)
56,580,216
(₹712.91 Cr.)
HNI2 (>10 LAKH)
158.99x
1,000,000
(₹12.60 Cr.)
158,988,879
(₹2003.26 Cr.)
RETAIL
34.86x
3,500,000
(₹44.10 Cr.)
122,010,581
(₹1537.33 Cr.)
Total
56.49x
7,000,000
395,430,812
*Excluding Anchor
Total No. of Application Approx : ~843295 (28.67 Appwise)
HNI Cost
About Company
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company markets products through three business units:
- National sales,
- International sales and
- Product partnering with various foreign and Indian pharmaceutical companies.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.
Strengths
- Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
- Large manufacturing capabilities
- Wide Domestic and International Marketing Network.
-
Experienced management team supported by a large, diverse and skilled workforce.
Company Promoters
Company Financials
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
Assets | 381.76 | 352.12 | 374.06 |
Total Income | 276.09 | 281.61 | 262.70 |
Profit After Tax | 10.50 | 3.63 | -2.11 |
EBITDA | 61.05 | 58.76 | 56.31 |
Net Worth | 96.39 | 66.29 | 62.88 |
Reserves and Surplus | 67.56 | 39.46 | 36.05 |
Total Borrowing | 195.00 | 205.23 | 215.66 |
Amount in ? Crore |
Objects of the Issue
The Company Amanta Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No. | Objects of the Issue | Expected Amount (? in crores) |
---|---|---|
1 | Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | 70.00 |
2 | Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | 30.13 |
3 | General corporate purposes |
How to Apply
Apply for IPO in few simple steps.
-
Step 1
Once you create your account, Login to Easy Investing.
-
Step 2
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
-
Step 3
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
-
Step 4
Enter your UPI ID and you will receive mandate on your UPI App.
-
Step 5
Once you accept the mandate, Application is submitted successful.
The Bidding Process
- Applying for an IPO is easier than ever with Easy Investing, in just a few clicks your application is processed. You can bid for any IPO through Easy Investing, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
- If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
- The maximum subscription amount for retail investors is 2 lakh.
- Any bid can be at a desired price or cut off price given by the company.
How to bid on App?
- Enter the number of shares you wish to buy, as per the lot size.
- You can apply at the cut off price set by the company or bid for a desired amount within the price band.
- Maximum three bids will be accepted.
- You then need to enter the UPI ID on Easy Investing’s IPO application form.
Investing using UPI
- You will immediately get a fund blocked request on your UPI for the submitted IPO application.
- The funds will be blocked in your bank account until allotment when it is debited.
- The limit for IPO application is Rs 2 lakh per transaction on UPI.
- On allotment of the shares, the money will be automatically debited.
- If the share aren’t allotted the blocked funds will reflect back into your account.
FAQs
Frequently Ask Question